Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study

Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study

NCT06386445 ·Status: NOT_YET_RECRUITING

Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut

NCT07305090 ·Status: RECRUITING

Using the Composite Immune Risk Score to Assess and Modulate the Patient's Post-transplant Immune Reconstitution.

NCT06208137 ·Status: RECRUITING ·Phase: NA

Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell Transplantation

NCT03423706 ·Status: UNKNOWN ·Phase: NA

Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

NCT07349498 ·Status: RECRUITING

Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation

NCT06704542 ·Status: NOT_YET_RECRUITING

Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)

NCT01879072 ·Status: COMPLETED

The Kinetics Profiling of Immune Reconstitution and Clinical Outcomes

NCT07113730 ·Status: NOT_YET_RECRUITING

Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia

NCT05335226 ·Status: UNKNOWN ·Phase: NA

Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA

NCT07299123 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2

Critical Illness After Hematopoietic Cell Transplantation

NCT07328724 ·Status: NOT_YET_RECRUITING

ALLO-SCT in Elderly Patients With Hematological Disease

NCT04386928 ·Status: COMPLETED

Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation

NCT06171906 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Clinical Study on the Impact of Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell Transplantation

NCT05587881 ·Status: WITHDRAWN

Role of aGVHD Biomarkers on aGVHD Risks

NCT04284904 ·Status: COMPLETED

Kidney and Hematopoietic Cell Transplants Using a Regimen to Promote Hematopoietic Cell Engraftment

NCT04571203 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)

NCT03904134 ·Status: COMPLETED ·Phase: NA

Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia

NCT01050036 ·Status: COMPLETED ·Phase: NA

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

NCT01890486 ·Status: RECRUITING

Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies

NCT00079391 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT

NCT06362967 ·Status: RECRUITING ·Phase: PHASE2

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies

NCT06294678 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Resiliency in Older Adults Undergoing Bone Marrow Transplant

NCT04188678 ·Status: COMPLETED

Umbilical Cord Mesenchymal Stem Cells as First-line Treatment for Patients With Acute Graft Versus Host Disease

NCT05531266 ·Status: UNKNOWN ·Phase: NA

Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies

NCT00275678 ·Status: COMPLETED ·Phase: PHASE3